Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)
EP Europace, 07/27/2012
Friberg L et al. – This hypothesis is that screening for AF will reduce stroke incidence in the screened population, and that this screening will prove to be cost effective. Secondary endpoints are: any thromboembolic event, intracranial bleeding, other major bleeding, first ever diagnosis of dementia, death from any cause, and a composite of these endpoints.



